Comments
FDA panel backs Gilead's Truvada to prevent HIV
11.05.2012. | WASHINGTON (Reuters) - A U.S. Food and Drug Administration panel of outside experts recommended Gilead Sciences Inc's Truvada as a treatment for preventing HIV infection among people at risk for contracting AIDS, including homosexual and bisexual men....
